Aducanumab for Alzheimer’s disease?-Reference-Cited by-同舟云学术

Aducanumab for Alzheimer’s disease?

Published:2021-07-05 Issue: Volume: Page:n1682
ISSN:1756-1833
Container-title:BMJ
language:en
Short-container-title:BMJ

Author:

Walsh Sebastian,Merrick Richard,Milne Richard,Brayne Carol

Publisher

BMJ

Subject

General Engineering

Reference13 articles.

1. Three FDA advisory panel members resign over approval of Alzheimer’s drug

2. Walsh S, King E, Brayne C. France removes state funding for dementia drugs. 2019.

3. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

4. US Food & Drug Administration. Combined FDA and applicant PCNS drugs advisory committee briefing document. 2020. https://www.fda.gov/media/143502/download

5. Effect of reductions in amyloid levels on cognitive change in randomized trials: instrumental variable meta-analysis

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of CXCR4: A perspective on miracle fruit seed for Alzheimer's disease treatment;Experimental Neurology;2024-09

2. Autoimmune hypothesis of Alzheimer’s disease: unanswered question;Journal of Neurophysiology;2024-09-01

3. Apolipoprotein E in Alzheimer’s Disease: Focus on Synaptic Function and Therapeutic Strategy;Molecular Neurobiology;2024-08-31

4. Lacticaseibacillus rhamnosus HA-114 and Bacillus subtilis R0179 Prolong Lifespan and Mitigate Amyloid-β Toxicity in C. elegans via Distinct Mechanisms;Journal of Alzheimer's Disease;2024-08-27

5. Fueling Alzheimer’s Disease: Where Does Immunometabolism Stand?;Journal of Alzheimer's Disease;2024-08-20